Search results
Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year?
Zacks via Yahoo Finance· 1 year agoThe Medical group has plenty of great stocks, but investors should always be looking for companies...
Arbutus (ABUS) Upgraded to Buy: Here's Why
Zacks via Yahoo Finance· 1 year agoArbutus (ABUS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock...
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
Zacks via Yahoo Finance· 2 months agoFor those looking to find strong Medical stocks, it is prudent to search for companies in the group...
Arbutus (ABUS) to Focus on Hepatitis B Candidates, Stock Up
Zacks via Yahoo Finance· 9 months agoArbutus (ABUS) makes a strategic decision to focus on the development of hepatitis B virus therapies...
Abus Powerdome MIPS helmet review – affordable all-rounder but potential fit issues
Bike Perfect via Yahoo Sports· 1 year agoAbus Powerdome MIPS helmet The German security giant Abus has long been respected for its...
Arbutus Biopharma (NASDAQ:ABUS) shareholders have endured a 78% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 10 months agoLong term investing is the way to go, but that doesn't mean you should hold every stock forever. It...
Arbutus Biopharma Corp (ABUS) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 8 months agoArbutus Biopharma Corp (NASDAQ:ABUS) reported Q3 2023 financial results on November 7, 2023. The...
Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 1 year agoArbutus (ABUS) delivered earnings and revenue surprises of 0% and 1.03%, respectively, for the...
Arbutus Biopharma Corporation's (NASDAQ:ABUS) top owners are individual investors with 43% stake,...
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Arbutus Biopharma Corporation (NASDAQ:ABUS) should be aware of the most powerful...
Analysts Just Shipped A Dazzling Upgrade To Their Arbutus Biopharma Corporation (NASDAQ:ABUS)...
Simply Wall St. via Yahoo Finance· 2 years agoArbutus Biopharma Corporation (NASDAQ:ABUS) shareholders will have a reason to smile today, with the...
